Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Mulia Industrindo Tbk (MLIA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Mulia Industrindo Tbk — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Mulia Industrindo Tbk trades at Rp240 (market cap 1.59T, 43.4K 24h volume). The key difference: Mulia Industrindo Tbk is far larger — about 5.1× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 43.4K). Which is the better fit depends on your goals.
| DGNS | MLIA | |
|---|---|---|
Market Cap | 310.75B | 1.59T |
Volume | 963.6K | 43.4K |
Lot | 9.64K | 434 |
Turnover | 217.67M | 10.42M |
Average Price | 225.89 | 240 |
Value | 217.67M | 10.42M |
Indicative Equilibrium Price | 226 | 240 |
Indicative Equilibrium Volume | 1K | 19 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Mulia Industrindo Tbk
PT Mulia Industrindo Tbk (the company) was established based on Deed No. 15 dated November 5, 1986 of Liliani Handajawati Tamzil S.H., notary in Jakarta, as amended by deed No. 7 dated May 6, 1987 of the same notary.. The company's articles of association have been amended several times, most recently on January 21, 1997 regarding the change of the Company's name and par value per share. The company is one of the companies of the Mulia Group. The company started its commercial operations in 1990.
Read more on MLIA →
